esophageal cancer

2021 ASCO Annual Meeting; #ASCO21
June 3, 2021
ASCO Staff

2021 ASCO Annual Meeting: New Treatments and Research Advances in Esophageal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Kidney Cancer, and Nasopharyngeal Cancer


The ASCO Annual Meeting begins on June 4, and here is some of the notable research that will be presented. Topics include combined immunotherapy for esophageal cancer, targeted radiation for mCRPC, olaparib for HER2-negative breast cancer, adjuvant chemotherapy for cervical cancer, pembrolizumab for kidney cancer, and toripalimab for nasopharyngeal cancer.

2019 ASCO ® Annual Meeting; #ASCO19
May 15, 2019
Greg Guthrie, ASCO staff

ASCO Annual Meeting 2019: An Early Look at This Year’s Research


Read research highlights that will be presented at the 2019 ASCO Annual Meeting, covering low-fat diets and risk of breast cancer death, chemotherapy for older adults with esophageal cancer, targeted therapy for those at risk for multiple myeloma, the rate of genetic changes in childhood cancers, and a new targeted therapy for childhood central nervous system tumors.

Subscribe to RSS - esophageal cancer